Venture Global LNG Raises $1.75 Billion in IPO

Cathie Wood is betting Donald Trump’s regulatory and growth agenda will revive the market for US initial public offerings.
Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...
Private equity firm Castle Creek Capital is among Northpointe's major shareholders. The bank had $5.4 billion in assets, as of Sept. 30, and has originated more than $190 billion in home loan ...
Dealmakers, who were gearing up for a busy year of initial public offerings, have already been confronted by a formidable ...
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
Smithfield Foods is targeting a valuation of up to $10.73 billion in its New York flotation, the biggest U.S. pork processor ...